| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.6 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |